Basketball star Steven Adams has invested in the NZ brain drink Ārepa. The NBA player has bought 1.44% of the company, saying he was fascinated by the science behind the drink. Ārepa makes nootropics, or brain supplements aimed at increasing cognitive performance for people under pressure and stress. It has just closed its latest capital raising round at NZ$3.2 million, with multiple high-profile investors, including Steven Adams, Zespri chief executive Dan Mathieson and Comvita founder Alan Bougen. Adams says it’s cool to support a company from New Zealand like Ārepa, to see the science behind the product and how it can help people. The company’s drink ingredients included blackcurrants, pine bark and L-theanine, a caffeine-free amino acid found in green tea.
- Herd Improvement Company LIC Is Paying Out More Than $2 Million In Compensation For Supplying Some Dairy Farmers Bad Sire Semen
- Alliance Group Is Rolling-Out Cutting-Edge AI Technology Designed To Identify Eating Quality In Beef And Lamb
- This Week Federated Farmers’ National Council Is Meeting – Colin Hurst Joins Mark Leishman On Round Up
- The New Government’s Backing For Wool In Public Sector Buildings Is A Vote Of Confidence In The Sector, Says Wools Of New Zealand
- Environment Southland Says It Will Continue With Plan Change Tuatahi